Addiction Therapeutics Market 2023-2027 Along with 5-Year Historic (2017-2021) Industry Size & Comparison of 20 Vendors and 11 Countries

NEW YORK, october 20, 2022 /PRNewswire/ — The Addiction Therapeutics Market share is expected to increase by USD 9.86 billion from 2022 to 2027, with an accelerated CAGR of 7.65% – according to the recent market study by Technavio. This report also offers a 5-year historic (2017-2021) data projection of market size, segment, and region. the YOY growth rate of the Addiction Therapeutics Market is estimated at 6.56% as of 2023. Moreover, the market is fragmented. Our analysts have conducted an internal and external analysis of vendors to help companies understand the wider business environment as well as the strength and weaknesses of key market players. Our report also forecasts the Bargaining Power of Buyers & Suppliers and the Threat of New Entrants & Rivalry ranging between LOW HIGH during the forecast period.

Technavio has announced its latest market research report titled Global Addictions Therapeutics Market 2023-2027

Technavio has announced its latest market research report titled Global Addictions Therapeutics Market 2023-2027

Find Analysis of Price Sensitivity, Lifecycle, Customer Purchase Basket, Adoption Rates, and Purchase Criteria Prepared Exclusively by Technavio Research Analysts

  • One of the core components of customer landscape is Price Sensitivity – an analysis of which will help companies refine marketing strategies to gain a competitive advantage.

  • Moreover, this report also provides impact of price sensitivity drivers (Purchases are undifferentiated, purchase is a key cost to the buyer, and quality is not important) which are expected to range between LOW HIGH from 2023-2027.

  • Our report provides extensive information on the customer landscape of the Addiction Therapeutics marketinvolving qualitative and quantitative intelligence.


The Addiction Therapeutics Market Report Also Offers Information on the Criticality of Inputs, R&D, Capex, Technology, Labor, and Brand of 20 Vendors Listed Below –

  • Amneal Pharmaceuticals Inc.

  • Aphios Corp.

  • Braeburn Inc.

  • Emergent BioSolutions Inc.

  • GlaxoSmithKline Plc

  • Glenmark Pharmaceuticals Ltd.

  • Hikma Pharmaceuticals Plc

  • Individual Plc

  • Johnson and Johnson

  • Kaleo Inc.

  • Mallinckrodt Plc

  • Orexo AB

  • Otsuka Holdings Co.Ltd.

  • Pfizer Inc.

  • Purdue Pharma LP

  • Sun Pharmaceutical Industries Ltd.

  • Teva Pharmaceutical Industries Ltd.

  • Titan Pharmaceuticals Inc.

  • Viatris Inc.


Chart & Data Table on 5-Year Historic (2017-2021) Market Size, Comparison and YOY Growth of Addiction Therapeutics Industry Segment

  • The market is segmented by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others) other Type (Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics, and Drug Addiction Therapeutics).

  • by distribution channel the hospital pharmacy segment shows a gradual increase in the demands for construction and other factors during 2023-2027.

  • Owing to the good discounts, improving reimbursement, and the growing number of drug addicts, Hospital pharmacies experience increasing demand for addiction therapeutics. These factors will positively impact the growth of the hospital pharmacy segment of the global addiction therapeutics market during the forecast period.

  • the growth of this segment is primarily attributed to the increasing adoption of the Addiction Therapeutics Market by residential consumerswhich is driven by changing lifestyles and a growing preference for comfort.


High Consumption of Alcohol, Tobacco, and Opioid Products is Notably Driving the Addiction Therapeutics Market Growth

Despite increasing awareness about and stringent regulations on the consumption of these products, the market has witnessed increase in the consumption of alcohol, opioids, and tobacco products. Opioids are a type of narcotic pain medication that is available as a therapy for the treatment of moderate-to-severe pain in many developed countries. However, the misuse and abuse of opioids lead to opioid tolerance and addiction. the high consumption of alcohol, tobacco, and opioid products on a daily basis can lead to a strong desire or sense of compulsion to consume the substance. This results in complications in controlling substance use behavior in terms of its onset, termination, and levels of use, which leads to substance use disorder, also known as substance dependency. Owing to the high consumption of these substances, the prevalence of substance use disorders has increased globally. Hence, the high consumption of these substances increases the prevalence of addiction globally, thereby driving the market growth.


Chart & Data Table on Historic Market Size (2017-2021), Comparison and YOY Growth of 11 Countries of Addiction Therapeutics Industry

  • The market is segmented by Geography NorthAmerica (The US and Canada), Europe (UK, Germany, Franceand rest of Europe), Asia (China, India, Japanand south korea), and Rest of World (ROW).

  • NorthAmerica is projected to grow at a percentage of 45% by 2022. NorthAmerica was the most significant contributing region in the global addictions therapeutics market, primarily owing to the increasing consumption of alcohol, tobacco, and opioids in the US and Canada. The consumption of alcohol, tobacco, and opioids is the leading cause of addiction in the US. The prevalence remains high among adults with mental health, disability, and substance use disorders.

  • In 2020, the COVID-19 pandemic negatively impacted most North American countries, which resulted in the temporary closure of various industries, including those manufacturing addiction therapeutics. The shutdowns adversely impacted their production and distribution activities. Also, as online channels were active even during the pandemic, there was an increased demand for addiction therapeutics. However, in 2021, the demand for addiction therapeutics rebounded from offline retail stores as regional activities resumed due to the COVID-19 vaccination drives and the subsequent lifting of lockdown restrictions.


Related Reports –

Alzheimers Disease Therapeutics Market by Drug Class and Geography – Forecast and Analysis 2022-2026 – The market share is expected to increase by USD 3.99 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 8.76%. Furthermore, this report extensively covers market segmentations by drug class (cholinesterase inhibitors, N-methyl-D-aspartate receptor antagonists, and other drug class) other geography (NorthAmerica, Europe, Asiaand Rest of World (ROW)). To get more exclusive research insights: VIEW SUMMARY OF THE REPORT FOR MORE

Gastrointestinal Stromal Tumors Therapeutics Market by Route of Administration and Geography – Forecast and Analysis 2022-2026 – The market share is expected to increase by USD 1.08 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 5.97%. The growing geriatric population is one of the key factors driving the market growth. To get more exclusive research insights: VIEW SUMMARY OF THE REPOR FOR MORE

Addiction Therapeutics Market Scope

report coverage


Page number


base year


Forecast period


Growth momentum & CAGR

Accelerate at a CAGR of 7.65%

Market growth 2023-2027

$9.86 billion

Market structure


YoY growth (%)


Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 45%

Key consumer countries

US, Canada, Germany, UK, and France

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Alkermes Public Ltd. Co., Amneal Pharmaceuticals Inc., Aphios Corp., Braeburn Inc., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Indivior Plc, Johnson and Johnson, kaleo Inc., Mallinckrodt Plc, Orexo AB, Otsuka Holdings Co. Ltd., Pfizer Inc., Purdue Pharma LP, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., and Viatris Inc.

Market Dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.

Customization preview

If our report has not included the data that you are looking for, you can reach out to our analysts and get customized segments.

Table of Contents

1 executive summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Distribution Channel

6 Market segmentation by type

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Trends

10 Vendor Landscape

11 Vendor analysis

12 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]

Global Addictions Therapeutics Market 2023-2027

Global Addictions Therapeutics Market 2023-2027



View original content to download multimedia:– comparison-of-20-vendors-and-11-countries-301653574.html

SOURCE Technavio

Leave a Comment